- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/12 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 491/12
Total number of patents in this class: 72
10-year publication summary
|
2
|
5
|
2
|
5
|
2
|
1
|
7
|
5
|
3
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hoffmann-La Roche Inc. | 3418 |
5 |
| ImmunoGen, Inc. | 399 |
4 |
| Novartis AG | 10849 |
2 |
| F. Hoffmann-La Roche AG | 7925 |
2 |
| The Trustees of Columbia University in the City of New York | 3568 |
2 |
| TP Therapeutics, Inc., AKA Turning Point Therapeutics | 9 |
2 |
| ALX Oncology, Inc. | 49 |
2 |
| Kymera Therapeutics, Inc. | 233 |
2 |
| SYNBLia Therapeutics, Inc. | 4 |
2 |
| Scinnohub Pharmaceutical Co., Ltd | 40 |
2 |
| Bristol-myers Squibb Company | 4898 |
1 |
| Genentech, Inc. | 3976 |
1 |
| AstraZeneca AB | 2909 |
1 |
| AstraZeneca UK Limited | 642 |
1 |
| Canon Inc. | 39888 |
1 |
| Centre National de La Recherche Scientifique | 10418 |
1 |
| Vertex Pharmaceuticals Incorporated | 1597 |
1 |
| University of Southern California | 2112 |
1 |
| University of Florida Research Foundation, Inc. | 4020 |
1 |
| Arizona Board of Regents, a Body Corporate of The State of Arizona Acting for and on Behalf of Arizona State University | 289 |
1 |
| Other owners | 37 |